Bicisate dihydrochloride
14344-58-2CCOC(=O)[C@H](CS)NCCN[C@@H](CS)C(=O)OCC.Cl.ClHKASNZKRIQURIX-BZDVOYDHSA-NSee also: Bicisate (has active moiety).
14344-58-2DTXSID4046656化学的特性Colourless solid
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
使用C143440 is radiopharmaceutical. Radiopharmaceutical is radioactive drug used for diagnosis or therapy in a tracer quantity with no pharmacological effect. The radiopharmaceuticals discussed include US Food and Drug Administration (FDA) approved tracers as well as those currently undergoing clinical trials that have yet to obtain FDA approval.
現在のフィルター条件では反応記録がありません。
読み込み中…